Search Results 2511-2520 of 77137 for Molecule
In this situation, low molecular weight heparin or a direct Factor Xa inhibitor is preferred. ... Patients who have been uneventfully anti-coagulated with a ...
... Molecular Pharmacology and Experimental Therapeutics. 2000. Henry W. Elliott AwardAmerican Society for Clinical Pharmacology and Therapeutics. 1998. Faculty ...
... molecules or even with an electric charge. ... D., a Mayo Clinic bioengineer, is developing polymers – multiple- molecule materials – that help bones regenerate ...
An issue with how blood flows in the heart. Changes in the protein called hemoglobin, which carries oxygen in red blood cells.
Our work focuses on evaluating the mechanisms of MDM2 inhibitor-mediated radiosensitization, identification of novel molecular biomarkers predicting ...
... molecular pharmacology and experimental therapeutics—grew in her ability to communicate technical information. Safgren and Austin in the lab. “It's always a ...
To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect. To ...
Vitamin E is an antioxidant. Antioxidants might protect cells from the effects of free radicals, which are molecules made when the body breaks down food or is ...
Due to lack of effective pharmacotherapies, identification of new molecular targets is needed. Telomeres are DNA sequences at the end of our chromosomes and ...
Mayo scientists are also studying the molecular genetics of hemophilia. This promising field of study may lead to gene therapy in the future. Publications.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!